Development and validation of a transcription factor regulatory network‐based signature for individualized prognostic risk in lung adenocarcinoma

Documenti analoghi

• Deciphering lung adenocarcinoma evolution: Integrative single‐cell genomics identifies the prognostic lung progression associated signature
  di: Pengpeng Zhang, et al.
  Pubblicazione: (2024)
• Clinical relevance of somatic mutations in Chinese lung adenocarcinoma and their prognostic implications for survival
  di: Tongxin Li, et al.
  Pubblicazione: (2024)
• The expression characteristic and prognostic role of Siglec‐15 in lung adenocarcinoma
  di: Haijun Sun, et al.
  Pubblicazione: (2024)
• Spatial transcriptomic analysis across histological subtypes reveals molecular heterogeneity and prognostic markers in early‐stage lung adenocarcinoma
  di: Hua Geng, et al.
  Pubblicazione: (2025)
• Identification and analysis of prognostic immune cell homeostasis characteristics in lung adenocarcinoma
  di: Yidan Sun, et al.
  Pubblicazione: (2024)